High myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas
International Journal of Cancer, 04/25/2012
Schrader A et al. – Our data provide new insights into the role of c-Myc activity in different lymphomas and raises the question of treatment changes for those patients under risk.
We investigated to which extent aberrant c-Myc activity plays a functional role in other aNHL and whether it is independent from MYC translocations.
Based on a combined microarray analysis of human germinal center (GC) B cells transfected with c-Myc and 220 aNHLs cases, we developed a “c-Myc index.”This index measures the extent to which lymphomas express c-Myc responsive genes. It comprises genes that are affected in a variety of tumors compared to normal tissue.
This supports the view that aberrant c-Myc expression in GC B cells triggers a tumor-like expression pattern.
As expected, the “c-Myc index” is very high in molecular Burkitt lymphoma (mBL), but more importantly also high within other aNHL.
It constitutes a negative prognostic marker independent of established risk factors and of the presence of a MYC translocation.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.